Researcher from First Affiliated Hospital of Harbin Medical University Details Findings in Influenza Vaccines (Influenza Vaccine Hesitancy among Cancer Survivors in China: A Multicenter Survey).

A recent study conducted in China found that many cancer survivors are hesitant to receive influenza vaccines, despite being at a higher risk for severe complications from the flu due to their compromised immune systems. The study, which surveyed 500 participants from five tertiary hospitals, revealed that 42.06% of cancer survivors reported vaccine hesitancy. Factors associated with vaccine hesitancy included concerns about vaccine safety, lack of information from doctors, and limited access to vaccination services. The researchers emphasized the importance of addressing these concerns and improving doctor-patient communication to increase influenza vaccine uptake among cancer survivors. [Extracted from the article]

Copyright of Cancer Vaccine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)